Fund manager
Baker Brothers Investments
Baker Brothers Investments · Biotech
Investor focused on biotechnology and life sciences. Added from a public list of the largest hedge fund managers.
Top holdings
| Company | Weight | Value |
|---|---|---|
| Incyte Corporation (INCY) | 17.5% | $3.5B |
| Beone Medicines Ltd. (ONC) | 12.6% | $2.5B |
| Revolution Medicines, Inc. (RVMD) | 10.8% | $2.1B |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 5.8% | $1.2B |
| Acadia Pharmaceuticals Inc. (ACAD) | 5.5% | $1.1B |
| Kymera Therapeutics, Inc. (KYMR) | 5.0% | $992.7M |
| Insmed Incorporated (INSM) | 4.7% | $937.8M |
| Celcuity Inc. (CELC) | 4.2% | $828.2M |
| Kodiak Sciences Inc. (KOD) | 3.9% | $776.1M |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 3.1% | $622.3M |
From the Form 13F for the quarter ended 2026-06-30, filed 2026-08-14. Reported $19.9B across 83 positions.